GENOMIC PROFILING IDENTIFIES TUBULIN MUTATIONS THAT MAY PREDICT RESPONSE TO DEPATUXIZUMAB MAFODOTIN IN PATIENTS WITH GLIOBLASTOMAA. B. Lassman,L. Roberts-Rapp,L. He,X. Lu,Z. Zha,A. Bhathena,P. J. Ansell,H. K. Gan,A. M. Scott,M. van den BentNeuro-oncology(2018)引用 2|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要